[go: up one dir, main page]

WO2012152966A1 - Cosmetic composition for couperosis care - Google Patents

Cosmetic composition for couperosis care Download PDF

Info

Publication number
WO2012152966A1
WO2012152966A1 PCT/ES2012/070261 ES2012070261W WO2012152966A1 WO 2012152966 A1 WO2012152966 A1 WO 2012152966A1 ES 2012070261 W ES2012070261 W ES 2012070261W WO 2012152966 A1 WO2012152966 A1 WO 2012152966A1
Authority
WO
WIPO (PCT)
Prior art keywords
cosmetic composition
couperose
skin
care
cream
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/ES2012/070261
Other languages
Spanish (es)
French (fr)
Inventor
Montserrat SABÁN NOGUERA
Josep Mª SUÑE NEGRE
Miguel HUGUET VIÑAS
Mª Angeles IZQUIERDO GADEA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LABORATORIOS STARGA SL
Original Assignee
LABORATORIOS STARGA SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LABORATORIOS STARGA SL filed Critical LABORATORIOS STARGA SL
Publication of WO2012152966A1 publication Critical patent/WO2012152966A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29Titanium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Definitions

  • the present invention relates to the use of a cosmetic composition comprising a cosmetically effective amount of stearyl glycyrrheinate, tocopheryl nicotinate, talc, titanium dioxide and shea butter for the preparation of a cosmetic composition for the care and treatment of couperose.
  • the present invention also relates to the method of application on the facial skin of said composition which comprises the steps of taking a sample of the cosmetic composition with an application device and applying it locally on the couperose and optionally applying heat on said couperose.
  • Cuperosis is an alteration in the form of dilation of the superficial capillaries of the skin of the face, mainly in the central area (cheeks, nose), whose origin is multifactorial.
  • causes that cause this disorder include a genetic predisposition, prior involvement with acne and / or rosacea, whose outbreaks subsequently lead to the presence of permanent superficial capillary dilations, as well as hormonal and environmental changes.
  • Cosmetic treatments are topical products such as creams, tonics and makeup, aimed at alleviating the burning sensation and redness that is usually linked to couperose, and that cover, camouflaging venous dilations. These cosmetic products are not included in the European Pharmacopoeia, and due to their cost-benefit balance, only a small part of the population is willing to use them.
  • the present invention solves the drawbacks of the state of the art by referring to a cosmetic composition of topical administration located on the couperose (non-invasive) that allows the patient the controlled administration thereof without the safety and toxicity problems they pose. surgical treatments as well as cosmetic treatments known in the state of the art.
  • the present invention proposes a topical cream of cosmetic action that is very advantageous to reduce the aforementioned effects as well as the unsightly problems caused by couperose.
  • the composition object of the present invention has the advantage that it also lacks corticosteroids which also makes it possible for its continued use without causing side effects, such as skin winding and the appearance of stretch marks and fissures.
  • a first important aspect of the present invention refers to the use of a cosmetic composition comprising a cosmetically effective amount of stearyl glycyrrheinate, tocopheryl nicotinate, talc, titanium dioxide and shea butter for the preparation of a cosmetic composition for the Cuperosis care and treatment. Additional aspects of the present invention protect the use of the aforementioned cosmetic composition topically in the form of a cream and / or emulsion, as well as the use of said composition to make up and disguise couperose.
  • the present invention also relates to the use of said composition topically by an application device selected from the group consisting of: a brush, a spatula, a cotton pad, gauze and a swab, sponge, tube with applicator.
  • an application device selected from the group consisting of: a brush, a spatula, a cotton pad, gauze and a swab, sponge, tube with applicator.
  • the present invention also protects the method of application on the facial skin of said composition comprising the steps of taking a sample of the cosmetic composition with an application device and applying it locally on the couperose and optionally applying heat on said couperose.
  • composition cited above is obtained with the following method: Aqueous PHASE (A):
  • NIKKOSOME OS squalene + glycerin + hydrogenated lecithin
  • glycyretinic acid is a complex triterpene that is used locally in preparations for the treatment of non-infectious inflammatory disorders of the skin, it is also a potent inhibitor of the 11-b-hydroxysteroid dehydrogenase enzyme that inactivates cortisol.
  • glycyrrhizinic acid can be esterified with stearyl alcohol, which favors its absorption through the skin, acting as stearyl alcohol as a vehicle, conferring an emollient, moisturizing and surfactant action.
  • Stearyl glycyrrheinate a derivative of glycyrrhizinic acid is involved in skin whitening, therefore being used in sunscreen preparations because it has an inhibitory effect of melanogenesis.
  • stearyl glycyrrheinate has been selected as an active compound because it increases lipid solubility and has anti-inflammatory properties at low concentrations.
  • Tocopheryl nicotinate is a substance with lipid-lowering and vasodilatory properties, which is why it is commonly used in the treatment of hyperlipidemias, in peripheral vasculopathies (atherosclerotic or occlusive vasculopathy, as well as venous disorders resulting from atherosclerosis, a vasospasm or a thromboembolism) as well as Cerebrovascular diseases.
  • tocopheryl nicotinate favors oxygenation of the hair bulb and skin microcirculation, it also has an antioxidant and conditioning function of the skin, not being an irritating or sensitizing compound.
  • the purified talc used topically, relieves irritation and prevents chafing. It is usually mixed with starch and zinc oxide, to increase moisture absorption.
  • the purified talc is also used as a lubricant and diluent excipient in the manufacture of tablets and capsules, and for bleaching liquids.
  • Talc is also used as a sclerosant in malignant effusions and in recurrent spontaneous pneumothorax.
  • talc is used to facilitate application and dispersion as well as offers slip and adhesion properties. Its coverage power and moisture absorption capacity are relatively low. Therefore, it is frequently combined with other products such as kaolin and zinc oxide.
  • Titanium dioxide is one of the whitest chemical substances that exist: It reflects practically all the visible radiation that comes to it and keeps the color permanently. It is one of the substances with the highest refractive index, even pulverized or mixed with other substances. And for the same reason, it is very opaque and that is why it serves to protect from sunlight. Titanium dioxide pigments are also used in cosmetics as ultraviolet absorbers in cosmetic products. Titanium dioxide also has the advantages of being harmless, of being compatible with mucous membranes and skin and having good dispersibility in organic solutions. That is why in the field of cosmetics titanium dioxide is commonly used as an ingredient. In addition, titanium dioxide has an action on the skin similar to that of zinc oxide and is used together with titanium peroxide and titanium salicylate in the treatment of diaper rash.
  • titanium dioxide that it is not absorbed, that is, the titanium dioxide pigments when analyzed were only found in the stratum corneum of the skin.
  • Shea butter has a protective action against dry skin, being moisturizing for both skin and hair. It also has a protective action against solar erythema, prevents and treats skin aging, stimulates the metabolism of cells and prevents wrinkles.
  • Shea butter also has a healing action of wounds, suitable for the treatment of squamous dermis, for dry and cracked hands, for the treatment of ulcers, eczema and stretch marks on the skin.
  • phase (O) in an appropriate container and in the same bath, heat phase (A) to 80 ° C ( ⁇ 2 ° C). With phases (O) and (A) at the same temperature, manually stir the phase (O) and add slowly and while stirring the phase (A). While stirring, remove the mixture from the bath.
  • phase (D) tocopheryl nicotinate
  • phase (B) is and work with the mortar hand until obtaining a cream with a homogeneous texture and color. Pass the obtained cream to a container and cover well.
  • a homogeneous flesh-colored cream is obtained. After 24 h of its preparation, the consistency of the cream increases until a paste is obtained that applied on top of the skin forms a consistent and well adhered layer, resistant to water (slips when it falls from the tap on the skin) but easily removable by rubbing with Water and shower gel.
  • the cream obtained is suitable for topical application, presenting good organoleptic, covering, bioadhesive and water resistance characteristics.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to the use of a cosmetic composition in the form of a cream, which comprises a cosmetically effective amount of stearyl glycyrrhetinate, tocopheryl nicotinate, talc, titanium dioxide and shea butter, for the preparation of a cosmetic composition for the care and treatment of couperosis, and to the method for the administration thereof.

Description

COMPOSTCT N C SMFTT A PAR A FT CTTTDAD DF T A CTTPFROSTS  COMPOSTCT N C SMFTT A PAR A FT CTTTDAD DF T A CTTPFROSTS

D E S f R I P n Ó N D E S f R I P n Ó N

OBJETO DE LA INVENCIÓN OBJECT OF THE INVENTION

La presente invención se refiere al uso de una composición cosmética que comprende una cantidad cosméticamente efectiva de glicirretinato de estearilo, nicotinato de tocoferilo, talco, dióxido de titanio y manteca karité para la preparación de una composición cosmética para el cuidado y tratamiento de cuperosis. La presente invención también se refiere al método de aplicación sobre la piel facial de dicha composición que comprende las etapas de tomar una muestra de la composición cosmética con un dispositivo de aplicación y aplicar de forma localizada sobre la cuperosis y aplicar opcionalmente calor sobre dicha cuperosis. The present invention relates to the use of a cosmetic composition comprising a cosmetically effective amount of stearyl glycyrrheinate, tocopheryl nicotinate, talc, titanium dioxide and shea butter for the preparation of a cosmetic composition for the care and treatment of couperose. The present invention also relates to the method of application on the facial skin of said composition which comprises the steps of taking a sample of the cosmetic composition with an application device and applying it locally on the couperose and optionally applying heat on said couperose.

ANTECEDENTES DE LA INVENCIÓN BACKGROUND OF THE INVENTION

La cuperosis es una alteración en forma de dilatación de los capilares superficiales de la piel de la cara, fundamentalmente en la zona central (mejillas, nariz), cuyo origen es multifactorial. Entre las causas que originan este trastorno se incluye una predisposición genética, la afectación previa por un acné y/o rosácea, cuyos brotes conllevan posteriormente la presencia de dilataciones capilares superficiales permanentes, así como cambios hormonales y ambientales. Cuperosis is an alteration in the form of dilation of the superficial capillaries of the skin of the face, mainly in the central area (cheeks, nose), whose origin is multifactorial. Among the causes that cause this disorder include a genetic predisposition, prior involvement with acne and / or rosacea, whose outbreaks subsequently lead to the presence of permanent superficial capillary dilations, as well as hormonal and environmental changes.

Se trata pues de una alteración que conlleva enrojecimiento permanente de la cara, que empeora por vasodilatación con los cambios bruscos de temperatura ambiental (calor-frío, locales cerrados, etc.) comportando preocupación, inseguridad y disminución de la autoestima de las personas que lo padecen {Balkrishnan R, McMichael Aj, Hu JY et al. Correlates of health-related quality oflife in women with severe facial blemishes. Int Soc Dermatol.2006; 45: 111-115). It is therefore an alteration that involves permanent reddening of the face, which is worsened by vasodilation with the sudden changes in ambient temperature (hot-cold, closed premises, etc.) leading to concern, insecurity and decreased self-esteem of people who suffer {Balkrishnan R, McMichael Aj, Hu JY et al. Correlates of health-related quality oflife in women with severe facial blemishes. Int Soc Dermatol. 2006; 45: 111-115).

No se disponen de cifras exactas de incidencia porque no existe una definición uniforme del cuadro clínico que presenta este tipo de afección. La dificultad estriba en definir el punto en el cual un paciente con mejillas sonrosadas presenta un problema dermatológico, tipo rosácea. Sin embargo, un estudio sueco publicó una incidencia del 10%, que es un porcentaje razonable como para tener en cuenta el tratamiento y cuidado de este tipo de pacientes {Berg M, Liden S. An epidemiological study of rosacea. Acta Dermatovenerol. 1989; 69: 419-23). Exact incidence figures are not available because there is no uniform definition of the clinical picture presenting this type of condition. The difficulty lies in defining the point at which a patient with pink cheeks presents a dermatological problem, rosacea type. However, a Swedish study published an incidence of 10%, which is a reasonable percentage to take into account the treatment and care of such patients {Berg M, Liden S. An epidemiological study of rosacea. Dermatovenerol Act. 1989; 69: 419-23).

Actualmente, existen distintos tratamientos para paliar o eliminar estas alteraciones, que se pueden resumir en los siguientes: Currently, there are different treatments to alleviate or eliminate these alterations, which can be summarized as follows:

- Tratamientos cosméticos- Se trata de productos tópicos como cremas, tónicos y maquillajes, dirigidos a paliar la sensación de ardor y enrojecimiento que habitualmente va ligada a la cuperosis, y que cubren, camuflando las dilataciones venosas. Estos productos cosméticos no están incluidos en la Farmacopea Europea, y debido al balance beneficio-coste de los mismos, sólo una pequeña parte de la población está dispuesta a utilizarlos. - Cosmetic treatments - These are topical products such as creams, tonics and makeup, aimed at alleviating the burning sensation and redness that is usually linked to couperose, and that cover, camouflaging venous dilations. These cosmetic products are not included in the European Pharmacopoeia, and due to their cost-benefit balance, only a small part of the population is willing to use them.

- Tratamientos quirúrgicos- Existen varios procedimientos que son útiles para eliminar los capilares que constituyen la cuperosis. Hasta hace unos años se utilizaba la electrocoagulación de las venas faciales, de una en una, lo que comportaba dolor y con frecuencia cicatrices residuales. Actualmente se emplea con éxito la tecnología láser/IPL (láser de Luz Intensa Pulsada) para el tratamiento de cuperosis. Tanto los láseres de colorante pulsado, como al Neodimio: Yag (láser generalmente de 1064 nm) y la luz intensa pulsada (IPL) consiguen, actuando selectivamente sobre los trayectos venosos su paulatina disminución y eliminación. Son técnicas que no precisan anestesia ni medicación analgésica, pero son necesarias varias sesiones, y el coste es elevado. Son tecnologías de vanguardia, que requieren ser efectuadas por un médico experto, y aún así existe un riesgo de lesiones residuales hipo- hiperpigmentadas, por ello, aunque es el tratamiento actual de elección para tratar la cuperosis, su coste limita su utilidad a una porción reducida de pacientes. - Surgical treatments - There are several procedures that are useful for removing capillaries that constitute couperose. Until a few years ago, electrocoagulation of the facial veins was used, one at a time, which involved pain and often residual scars. Currently, the laser / IPL technology (Intense Pulsed Light Laser) is used successfully for the treatment of couperose. Both pulsed dye lasers and Neodymium: Yag (laser generally 1064 nm) and intense pulsed light (IPL) achieve, gradually acting on the venous paths, their gradual decrease and elimination. They are techniques that do not require anesthesia or analgesic medication, but several sessions are necessary, and the Cost is high. They are avant-garde technologies, which need to be carried out by an expert doctor, and there is still a risk of hypopigmented residual lesions, therefore, although it is the current treatment of choice to treat couperose, its cost limits its usefulness to a portion reduced patient

Existe por tanto la necesidad de encontrar una alternativa no invasiva, segura, efectiva, rápida y eficaz para el cuidado y/o tratamiento cosmético de la cuperosis que conlleve una disminución real del emojecimiento facial, que le facilite al paciente la correcta y cómoda administración del mismo, sin que suponga un riesgo para la salud debido a que es un producto correctivo y reparador de administración tópica sobre la piel. There is therefore a need to find a non-invasive, safe, effective, rapid and effective alternative for the care and / or cosmetic treatment of couperose that leads to a real decrease in facial emotion, which facilitates the patient the correct and comfortable administration of the same, without involving a health risk because it is a corrective and reparative product of topical administration on the skin.

De este modo la presente invención soluciona los inconvenientes del estado de la técnica al referirse a una composición cosmética de administración tópica localizada sobre la cuperosis (no invasiva) que permite al paciente la administración controlada de la misma sin los problemas de seguridad y toxicidad que plantean los tratamientos quirúrgicos así como los tratamientos cosméticos conocidos en el estado de la técnica. In this way the present invention solves the drawbacks of the state of the art by referring to a cosmetic composition of topical administration located on the couperose (non-invasive) that allows the patient the controlled administration thereof without the safety and toxicity problems they pose. surgical treatments as well as cosmetic treatments known in the state of the art.

DESCRIPCIÓN DE LA INVENCIÓN DESCRIPTION OF THE INVENTION

En la actualidad son frecuentes los problemas de cuperosis, con las consiguientes molestias que ello conlleva para los pacientes afectados, en su estado físico, además de las limitaciones a que da lugar, coartando en muchos casos la actividad, con impedimento incluso para el desarrollo de determinadas funciones de trabajo, deporte, etc. Currently, the problems of couperose are frequent, with the consequent discomfort that this entails for the affected patients, in their physical state, in addition to the limitations that it gives rise, in many cases restricting the activity, with impediment even for the development of certain functions of work, sport, etc.

En este sentido para paliar en lo posible esas molestias y consecuencias perjudiciales de la cuperosis sobre todo por el efecto antiestético, de acuerdo con el objeto de la presente invención se propone una crema tópica, de acción cosmética que resulta muy ventajosa para aminorar los mencionados efectos así como los problemas antiestéticos producidos por la cuperosis. La composición objeto de la presente invención, presenta la ventaja de que además carece de corticoides lo cual hace además posible su uso continuado sin que ocasione efectos secundarios, tales como arrollamiento de la piel y la aparición de estrías y fisuras. Un primer aspecto importante de la presente invención es que se refiere al uso de una composición cosmética que comprende una cantidad cosméticamente efectiva de glicirretinato de estearilo, nicotinato de tocoferilo, talco, dióxido de titanio y manteca karité para la preparación de una composición cosmética para el cuidado y tratamiento de cuperosis. Aspectos adicionales de la presente invención protegen el uso de la composición cosmética anteriormente citada por vía tópica en forma de crema y/o emulsión, así como el uso de dicha composición para maquillar y disimular la cuperosis. In this sense, to alleviate as much as possible these inconveniences and harmful consequences of couperose, especially due to the unsightly effect, in accordance with the purpose of the The present invention proposes a topical cream of cosmetic action that is very advantageous to reduce the aforementioned effects as well as the unsightly problems caused by couperose. The composition object of the present invention has the advantage that it also lacks corticosteroids which also makes it possible for its continued use without causing side effects, such as skin winding and the appearance of stretch marks and fissures. A first important aspect of the present invention is that it refers to the use of a cosmetic composition comprising a cosmetically effective amount of stearyl glycyrrheinate, tocopheryl nicotinate, talc, titanium dioxide and shea butter for the preparation of a cosmetic composition for the Cuperosis care and treatment. Additional aspects of the present invention protect the use of the aforementioned cosmetic composition topically in the form of a cream and / or emulsion, as well as the use of said composition to make up and disguise couperose.

La presente invención también se refiere al uso de dicha composición por vía tópica mediante un dispositivo de aplicación seleccionado del grupo formado por: un pincel, una espátula, un algodón, gasa y una torunda, esponja, tubo con aplicador. The present invention also relates to the use of said composition topically by an application device selected from the group consisting of: a brush, a spatula, a cotton pad, gauze and a swab, sponge, tube with applicator.

La presente invención protege asimismo el método de aplicación sobre la piel facial de dicha composición que comprende las etapas de tomar una muestra de la composición cosmética con un dispositivo de aplicación y aplicar de forma localizada sobre la cuperosis y aplicar opcionalmente calor sobre dicha cuperosis. The present invention also protects the method of application on the facial skin of said composition comprising the steps of taking a sample of the cosmetic composition with an application device and applying it locally on the couperose and optionally applying heat on said couperose.

La composición citada anteriormente se obtiene con el siguiente método: FASE (A) ACUOSA: The composition cited above is obtained with the following method: Aqueous PHASE (A):

En un vaso de precipitados pesar el agua destilada, con ayuda de un agitador magnético añadir el maltitol y agitar con agitación magnética hasta total disolución. Añadir NIKKOSOME OS (escualeno + glicerina + lecitina hidrogenada), y opcionalmente seda hidrolizada y agitar hasta total dispersión. Tapar y guardar hasta su utilización.  In a beaker, weigh the distilled water, with the help of a magnetic stirrer add the maltitol and stir with magnetic stirring until completely dissolved. Add NIKKOSOME OS (squalene + glycerin + hydrogenated lecithin), and optionally hydrolyzed silk and stir until completely dispersed. Cover and store until used.

FASE (B) ALCOHOLICA: PHASE (B) ALCOHOLIC:

En un vaso de precipitados pesar etanol 96°, pesar propilenglicol, dietilenglicol monoetil éter añadir y agitar en un agitador magnético hasta su disolución. Pesar el resto de los componentes (conservantes y silicona) y añadir uno a uno hasta su total disolución. Guardar tapado hasta su utilización.  In a beaker weigh 96 ° ethanol, weigh propylene glycol, diethylene glycol monoethyl ether add and stir on a magnetic stirrer until dissolved. Weigh the rest of the components (preservatives and silicone) and add one by one until completely dissolved. Keep covered until use.

FASE (C) FASE INSOLUBLES: PHASE (C) INSOLUBLE PHASE:

Pesar cada uno de los componentes (colorante, talco y dióxido de titanio) y pasarlos a un mortero. Mezclar homogéneamente y pasar la mezcla por un tamiz de 0,600 mm luz de malla. Volver la mezcla al mortero, homogeneizar y guardar tapado hasta su utilización. FASE (D) nicotinato de tocoferilo: Weigh each of the components (dye, talc and titanium dioxide) and transfer them to a mortar. Mix homogeneously and pass the mixture through a 0.600 mm light mesh screen. Return the mixture to the mortar, homogenize and keep covered until used. PHASE (D) tocopheryl nicotinate:

Pesar en un vidrio de reloj nicotinato de tocoferilo. Preservar de la luz y del aire. Guardar hasta su utilización.  Weigh in a tocopheryl nicotinate watch glass. Preserve from light and air. Save until use.

FASE (O) OLEOSA: OLEOUS (O) PHASE:

Pesar vaselina filante en un vaso de precipitados de 250 mi y poner a fundir en un baño Pesar uno a uno el resto de componentes de esta fase (parafina líquida, ciclometicona pentámera, glicirretinato de estearilo, tribehenina, propilenglicol dicaprilato, ésteres de colesterol y lanoesterol, sorbitan laurato y la manteca karité) y añadir al vaso que contiene vaselina filante. Calentar hasta 80 °C (±2 °C) hasta la total fusión de todos los componentes. Mantener la mezcla fundida a 80 °C (±2 °C). Weigh the petroleum jelly in a 250 ml beaker and melt in a bath Weigh the rest of the components of this phase one by one (liquid paraffin, pentamer cyclomethicone, stearyl glycyrrhecinate, tribehenine, dicaprilat propylene glycol, cholesterol esters and lanoesterol , sip laurate and shea butter) and add to the glass that contains petroleum jelly. Heat up to 80 ° C (± 2 ° C) to total fusion of all components. Keep the molten mixture at 80 ° C (± 2 ° C).

Las propiedades beneficiosas de esta crema se deben a la selección y proporción de cada uno de los componentes de la crema. The beneficial properties of this cream are due to the selection and proportion of each of the components of the cream.

Por ejemplo el ácido glicirretínico es un triterpeno complejo que se utiliza de forma local en preparados para el tratamiento de trastornos inflamatorios no infecciosos de la piel, también es un potente inhibidor de la enzima 11-b-hidroxiesteroide deshidrogenasa que inactiva el cortisol. De hecho se ha demostrado que la aplicación concomitante de ácido glicirretínico junto con hidrocortisona potencia la actividad de esta última en la piel. Otra propiedad que posee el ácido glicirretínico es que puede esterificarse con alcohol estearílico lo cual favorece su absorción a través de la piel actuando el alcohol estearílico como vehículo, confiriendo una acción emoliente, humectante y tensioactiva. For example, glycyretinic acid is a complex triterpene that is used locally in preparations for the treatment of non-infectious inflammatory disorders of the skin, it is also a potent inhibitor of the 11-b-hydroxysteroid dehydrogenase enzyme that inactivates cortisol. In fact it has been shown that the concomitant application of glycyrrhizinic acid together with hydrocortisone enhances the activity of the latter in the skin. Another property of glycyrrhizinic acid is that it can be esterified with stearyl alcohol, which favors its absorption through the skin, acting as stearyl alcohol as a vehicle, conferring an emollient, moisturizing and surfactant action.

El glicirretinato de estearilo, un derivado del ácido glicirretínico está implicado en el blanqueamiento de la piel, utilizándose por tanto en preparados para la protección solar debido a que posee un efecto inhibitorio de la melanogénesis. En este sentido para la presente invención se ha seleccionado el glicirretinato de estearilo como compuesto activo porque aumenta la solubilidad de lípidos y tiene propiedades antiinflamatorias a bajas concentraciones. Stearyl glycyrrheinate, a derivative of glycyrrhizinic acid is involved in skin whitening, therefore being used in sunscreen preparations because it has an inhibitory effect of melanogenesis. In this sense for the present invention, stearyl glycyrrheinate has been selected as an active compound because it increases lipid solubility and has anti-inflammatory properties at low concentrations.

El nicotinato de tocoferilo es una sustancia con propiedades hipolipemiantes y vasodilatadoras, por ello se emplea comúnmente en tratamiento de las hiperlipidemias, en vasculopatías periféricas (vasculopatía aterosclerótica u oclusiva, así como trastornos venosos consecuencia de una aterosclerosis, un vasoespasmo o una tromboembolia) así como enfermedades cerebrovasculares. Tocopheryl nicotinate is a substance with lipid-lowering and vasodilatory properties, which is why it is commonly used in the treatment of hyperlipidemias, in peripheral vasculopathies (atherosclerotic or occlusive vasculopathy, as well as venous disorders resulting from atherosclerosis, a vasospasm or a thromboembolism) as well as Cerebrovascular diseases.

Para el objeto de la presente invención el nicotinato de tocoferilo favorece la oxigenación del bulbo piloso y la microcirculación cutánea, además presenta una función antioxidante y acondicionadora de la piel no siendo un compuesto irritante ni sensibilizante. El talco purificado, utilizado por vía tópica, alivia la irritación y previene las rozaduras. Generalmente se mezcla con almidón y óxido de zinc, para incrementar la absorción de la humedad. El talco purificado también se usa como excipiente lubricante y diluyente en la fabricación de comprimidos y cápsulas, y para blanquear líquidos. El talco también se utiliza como esclerosante en los derrames malignos y en el neumotorax espontáneo recidivante. For the purpose of the present invention, tocopheryl nicotinate favors oxygenation of the hair bulb and skin microcirculation, it also has an antioxidant and conditioning function of the skin, not being an irritating or sensitizing compound. The purified talc, used topically, relieves irritation and prevents chafing. It is usually mixed with starch and zinc oxide, to increase moisture absorption. The purified talc is also used as a lubricant and diluent excipient in the manufacture of tablets and capsules, and for bleaching liquids. Talc is also used as a sclerosant in malignant effusions and in recurrent spontaneous pneumothorax.

Para el campo cosmético, el talco se utiliza para facilitar la aplicación y la dispersión así como ofrece propiedades de deslizamiento y adhesión. Su poder de cobertura y la capacidad de absorción de la humedad son relativamente bajas. Por ello se combina frecuentemente con otros productos como caolín y óxido de zinc. For the cosmetic field, talc is used to facilitate application and dispersion as well as offers slip and adhesion properties. Its coverage power and moisture absorption capacity are relatively low. Therefore, it is frequently combined with other products such as kaolin and zinc oxide.

El dióxido de titanio es una de las sustancias químicas más blancas que existen: Refleja prácticamente toda la radiación visible que le llega y mantienen el color de forma permanente. Es una de las sustancias con el índice de refracción más alto, incluso pulverizado o mezclado con otras sustancias. Y por la misma razón, es muy opaco y por eso sirve para proteger de la luz solar. Los pigmentos del dióxido de titanio también se emplean en cosmética como absorbentes de los rayos ultravioleta en productos cosméticos. El dióxido de titanio además posee las ventajas de ser inocuo, de ser compatible con las mucosas y la piel y tener buena dispersabilidad en soluciones orgánicas. Por eso en el campo de la cosmética el dióxido de titanio se utiliza comúnmente como ingrediente. Además el dióxido de titanio posee una acción sobre la piel similar a la del óxido de zinc y se utiliza junto con el peróxido de titanio y el salicilato de titanio en el tratamiento del eritema de los pañales. Titanium dioxide is one of the whitest chemical substances that exist: It reflects practically all the visible radiation that comes to it and keeps the color permanently. It is one of the substances with the highest refractive index, even pulverized or mixed with other substances. And for the same reason, it is very opaque and that is why it serves to protect from sunlight. Titanium dioxide pigments are also used in cosmetics as ultraviolet absorbers in cosmetic products. Titanium dioxide also has the advantages of being harmless, of being compatible with mucous membranes and skin and having good dispersibility in organic solutions. That is why in the field of cosmetics titanium dioxide is commonly used as an ingredient. In addition, titanium dioxide has an action on the skin similar to that of zinc oxide and is used together with titanium peroxide and titanium salicylate in the treatment of diaper rash.

Se ha demostrado en la utilización tópica del dióxido de titanio que no se absorbe, es decir, los pigmentos de dióxido de titanio al ser analizados solo se encontraron en el estrato córneo de la piel. It has been demonstrated in the topical use of titanium dioxide that it is not absorbed, that is, the titanium dioxide pigments when analyzed were only found in the stratum corneum of the skin.

La manteca de karité, posee una acción protectora contra la sequedad de la piel, siendo hidratante tanto para piel como para cabello. Además posee una acción protectora contra eritemas solares, previene y trata el envejecimiento cutáneo, estimula el metabolismo de las células y previene las arrugas. Shea butter, has a protective action against dry skin, being moisturizing for both skin and hair. It also has a protective action against solar erythema, prevents and treats skin aging, stimulates the metabolism of cells and prevents wrinkles.

La manteca de karité también tiene una acción cicatrizante de heridas, apta para el tratamiento de dermis escamosas, para manos secas y agrietadas, para el tratamiento de úlceras, eccemas y estrías en la piel. Shea butter also has a healing action of wounds, suitable for the treatment of squamous dermis, for dry and cracked hands, for the treatment of ulcers, eczema and stretch marks on the skin.

FORMACIÓN DE LA CREMA: CREAM FORMATION:

En un recipiente apropiado fundir la fase (O) y en el mismo baño, poner a calentar la fase (A) hasta 80 °C (±2 °C). Con las fases (O) y (A) a la misma temperatura, agitar manualmente la fase (O) y añadir despacio y sin dejar de agitar la fase (A). Sin dejar de agitar, apartar la mezcla del baño.  Melt phase (O) in an appropriate container and in the same bath, heat phase (A) to 80 ° C (± 2 ° C). With phases (O) and (A) at the same temperature, manually stir the phase (O) and add slowly and while stirring the phase (A). While stirring, remove the mixture from the bath.

Cuando la mezcla llegue a 50 °C y sin dejar de agitar, añadir la fase (D) (nicotinato de tocoferilo), hasta total incorporación. When the mixture reaches 50 ° C and while stirring, add phase (D) (tocopheryl nicotinate), until fully incorporated.

A continuación, sin dejar de agitar, añadir la fase (B), hasta total incorporación. En este punto se debe obtener una base de crema fluida de color blanco bien emulsionada. Pasar la base obtenida al mortero donde está la fase (C) y trabajar con la mano de mortero hasta obtener una crema de textura y color homogéneo. Pasar la crema obtenida a un envase y tapar bien. Then, while stirring, add phase (B), until fully incorporated. At this point you should obtain a well-emulsified white fluid cream base. Pass the base obtained to the mortar where phase (C) is and work with the mortar hand until obtaining a cream with a homogeneous texture and color. Pass the obtained cream to a container and cover well.

RTFMPT.OS DF RF.A T.T7. ACIÓN RTFMPT.OS DF RF.A T.T7. Action

Los siguientes ejemplos específicos que se proporcionan aquí sirven para ilustrar la naturaleza de la presente invención. Estos ejemplos se incluyen solamente con fines ilustrativos y no han de ser interpretados como limitaciones a la invención que aquí se reivindica. The following specific examples provided herein serve to illustrate the nature of the present invention. These examples are included for illustrative purposes only and should not be construed as limitations on the invention claimed herein.

Se obtiene una crema homogénea de color carne. Después de 24 h de su preparación aumenta la consistencia de la crema hasta obtenerse una pasta que aplicada encima de la piel forma una capa consistente y bien adherida, resistente al agua (resbala cuando cae desde el grifo sobre la piel) pero fácilmente eliminable frotando con agua y gel de ducha. A homogeneous flesh-colored cream is obtained. After 24 h of its preparation, the consistency of the cream increases until a paste is obtained that applied on top of the skin forms a consistent and well adhered layer, resistant to water (slips when it falls from the tap on the skin) but easily removable by rubbing with Water and shower gel.

La crema obtenida es adecuada para la aplicación tópica, presentando buenas características organolépticas, cubrientes, bioadhesivas y de resistencia a la acción del agua. The cream obtained is suitable for topical application, presenting good organoleptic, covering, bioadhesive and water resistance characteristics.

Claims

RFIVTNDTC A CTONF.S RFIVTNDTC TO CTONF.S 1. - Uso de una composición cosmética que comprende una cantidad cosméticamente efectiva de glicirretinato de estearilo, nicotinato de tocoferilo, talco, dióxido de titanio y manteca karité para la preparación de una composición cosmética para el cuidado y tratamiento de la cuperosis. 1. - Use of a cosmetic composition comprising a cosmetically effective amount of stearyl glycinate, tocopheryl nicotinate, talc, titanium dioxide and shea butter for the preparation of a cosmetic composition for the care and treatment of couperose. 2. - Uso de la composición cosmética según la según la reivindicación 1 caracterizada porque es de aplicación tópica en forma de crema y/o emulsión. 2. - Use of the cosmetic composition according to claim 1, characterized in that it is topically applied as a cream and / or emulsion. 3. - Uso de la composición cosmética según la según la reivindicación 1 para maquillar y disimular la cuperosis. 3. - Use of the cosmetic composition according to claim 1 to make up and conceal the couperose. 4. - Uso de la composición cosmética según la según las reivindicaciones 1 y 2 caracterizada porque es de aplicación tópica mediante un dispositivo de aplicación seleccionado del grupo formado por: un pincel, una espátula, un algodón, gasa y una torunda, esponja, tubo con aplicador. 4. - Use of the cosmetic composition according to claim 1 and 2, characterized in that it is applied topically by means of an application device selected from the group consisting of: a brush, a spatula, a cotton pad, gauze and a swab, sponge, tube with applicator 5. - Método de administración de la composición de reivindicación 1 caracterizado porque comprende las etapas de tomar una muestra de la composición cosmética con el dispositivo de aplicación, aplicar de forma localizada sobre la cuperosis y aplicar opcionalmente calor sobre dicha cuperosis. 5. - Method of administration of the composition of claim 1 characterized in that it comprises the steps of taking a sample of the cosmetic composition with the application device, applying it locally on the couperose and optionally applying heat on said couperose.
PCT/ES2012/070261 2011-05-11 2012-04-19 Cosmetic composition for couperosis care Ceased WO2012152966A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ESP201130752 2011-05-11
ES201130752A ES2392283B1 (en) 2011-05-11 2011-05-11 COSMETIC COMPOSITION FOR THE CARE OF IMPROVED COUPEROSIS.

Publications (1)

Publication Number Publication Date
WO2012152966A1 true WO2012152966A1 (en) 2012-11-15

Family

ID=47138820

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2012/070261 Ceased WO2012152966A1 (en) 2011-05-11 2012-04-19 Cosmetic composition for couperosis care

Country Status (2)

Country Link
ES (1) ES2392283B1 (en)
WO (1) WO2012152966A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2282547T3 (en) * 2002-08-17 2007-10-16 Beiersdorf Ag CONSMETIC BEAUTY PRODUCT.
US20070281047A1 (en) * 2003-10-24 2007-12-06 Cognis France, S.A.S. Composition Containing a Plant Extract and Process for Producing Same
ES2330291B1 (en) * 2008-02-29 2010-10-18 Lipotec Sa USEFUL PEPTIDES IN THE TREATMENT OF SKIN, MUCOSAS AND / OR LEATHER HAIR AND ITS USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673372B1 (en) * 1991-02-28 1993-10-01 Oreal COSMETIC COMPOSITION CAPABLE OF REDUCING SKIN DEFECTS.
DE102006055046A1 (en) * 2006-11-17 2008-05-21 Beiersdorf Ag Cosmetic formulation with glucosylglycerides and powder raw materials

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2282547T3 (en) * 2002-08-17 2007-10-16 Beiersdorf Ag CONSMETIC BEAUTY PRODUCT.
US20070281047A1 (en) * 2003-10-24 2007-12-06 Cognis France, S.A.S. Composition Containing a Plant Extract and Process for Producing Same
ES2330291B1 (en) * 2008-02-29 2010-10-18 Lipotec Sa USEFUL PEPTIDES IN THE TREATMENT OF SKIN, MUCOSAS AND / OR LEATHER HAIR AND ITS USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS.

Also Published As

Publication number Publication date
ES2392283A1 (en) 2012-12-07
ES2392283B1 (en) 2013-12-10

Similar Documents

Publication Publication Date Title
US8293288B2 (en) Pain relieving composition
EP2244690B1 (en) Topical compositions for treating inflammatory disorders, diseases and conditions
AU2016202140B2 (en) Compositions for skin exfoliation and use thereof
JP2024050723A (en) Photodynamic therapy for skin disorders
JP2006505583A5 (en)
AU2007293500B2 (en) Medicine for the treatment of acne and for reversing the signs of age and sun damage and method for using same
CN104800150A (en) Minoxidil cream and preparation method thereof
KR20060019540A (en) Topical Compositions for Transdermal Administration
DK2343038T3 (en) Dermatological compositions containing a combination of peroxidized lipids and zinc and their use, especially for the treatment of herpes
RU2702347C2 (en) Treating or preventing seborrheic keratosis using artemisinin and derivatives thereof
CN103006530B (en) Bee venom compound with sun-proof effect
WO2016054757A1 (en) Pharmaceutical composition for preventing, treating and curing rosacea, comprising snail slime, camomile and propolis
ES2605644T3 (en) Compositions and method for stimulating the female and male sexual response
ES2392283B1 (en) COSMETIC COMPOSITION FOR THE CARE OF IMPROVED COUPEROSIS.
WO2010092198A1 (en) Cosmetic composition for the care and correction of telangiectasias
CA3217338A1 (en) Topical formulations comprising benzoyl peroxide and azelaic acid, and use thereof
EP3378474B1 (en) Composition for the use in the treatment of plantar hyperhidrosis predisposing to cutaneous fungal infection of the foot
Chaves et al. Protocols for Drug Delivery
Shah et al. A Comprehensive Exploration of Topical Dosage Form in Ayurveda: A Review
ES2433249T3 (en) Extraction of skin changes
Zhou Clinical Application of Two Allergy-Relieving Formulas Replacing Topical Glucocorticosteroids in the Treatment of Cosmetic Dermatitis
ES2645535T3 (en) Topical compositions to treat inflammatory disorders, diseases and ailments
JP6659735B2 (en) Use of potassium hydroxide in the treatment of actinic keratosis
Diehl Chemical peeling in dermatology. Part II. Practical application, complications and their management
CN104666405A (en) Application of traditional Chinese medicine composition in preparing medicament for treating acne

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12782467

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12782467

Country of ref document: EP

Kind code of ref document: A1